Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9982944 | 0.98 | PPARD (0.45) | PPARD | |
| SCHEMBL5885579 | 0.98 | PPARD (0.45) | PPARD | |
| SCHEMBL7156934 | 0.86 | PPARD (0.34) | PPARD | |
| SCHEMBL7457883 | 0.80 | — | — | |
| SCHEMBL28224930 | 0.79 | PPARD (0.35) | PPARD | |
| SCHEMBL4534101 | 0.79 | ALDH1A1 (0.44) | — | |
| SCHEMBL8583417 | 0.79 | TYMS (0.31) | — | |
| SCHEMBL28500058 | 0.76 | LPAR3 (0.41) | — | |
| SCHEMBL10425332 | 0.75 | — | — | |
| SCHEMBL31650906 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559704-B2 | Microelectronic device cleaning composition | ENTEGRIS, INC. (US) | 2026-02-24 | — | — | US | claimed |
| US-20250277171-A1 | COMPOSITION FOR POST-CMP CLEANING | ENTEGRIS, INC. | 2025-09-04 | — | — | US | claimed |
| CN-120127138-A | Lithium iron phosphate positive electrode material, preparation method thereof and lithium ion battery | 广东邦普循环科技有限公司 | 2025-06-10 | — | — | CN | claimed |
| WO-2025102463-A1 | PRECURSOR, PREPARATION METHOD THEREFOR, POSITIVE ELECTRODE MATERIAL, POSITIVE ELECTRODE SHEET AND LITHIUM ION BATTERY | 湖北亿纬动力有限公司 | 2025-05-22 | — | — | WO | claimed |
| CN-119978882-A | Graphene nanocomposite, modified anticorrosive paint thereof and preparation method | 南京理工大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119776089-A | Cleaning compositions and methods of use thereof | 富士胶片电子材料美国有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119650594-A | Zinc-doped aluminum oxide-lithium metal composite negative electrode and preparation method thereof | 江西云威新材料股份有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-115397572-B | Cleaning compositions and methods of use thereof | 富士胶片电子材料美国有限公司 | 2024-12-31 | — | — | CN | claimed |
| EP-4419619-A1 | SELECTIVE WET ETCH COMPOSITION AND METHOD | Entegris, Inc. (US) | 2024-08-28 | — | — | EP | claimed |
| CN-117509594-A | Precursor and preparation method thereof, positive electrode material, positive electrode plate and lithium ion battery | 湖北亿纬动力有限公司 | 2024-02-06 | — | — | CN | claimed |
| US-5360550-A | Water treatment by adding phosphonated poly(meth)acrylic acid or salt; inhibiting barium sulfate precipitation | FMC CORPORATION (US) | 1994-11-01 | — | — | US | claimed |
| EP-0610333-A1 | TREATED APATITE PARTICLES FOR MEDICAL DIAGNOSTIC IMAGING | MALLINCKRODT MEDICAL, INC. (US) | 1994-08-17 | — | — | EP | claimed |
| EP-0480589-B1 | Scale inhibition | FMC CORP UK LTD (GB) | 1994-08-17 | — | — | EP | claimed |
| US-5294371-A | Hydroxyphosphonoacetic acid derivatives | FMC CORPORATION (US) | 1994-03-15 | — | — | US | claimed |
| EP-0544345-A1 | Corrosion and/or scale inhibition | FMC CORPORATION (UK) LIMITED (GB) | 1993-06-02 | — | — | EP | claimed |
| WO-1993007905-A2 | TREATED APATITE PARTICLES FOR MEDICAL DIAGNOSTIC IMAGING | MALLINCKRODT MEDICAL, INC. (US) | 1993-04-29 | — | — | WO | claimed |
| US-5160630-A | Adding organic carboxylated phosphite or salt compound; prevention of calcium carbonate precipitation | FMC CORPORATION (US) | 1992-11-03 | — | — | US | claimed |
| EP-0480589-A1 | Scale inhibition | FMC CORPORATION (UK) LIMITED (GB) | 1992-04-15 | — | — | EP | claimed |
| EP-0479465-A2 | Inhibition of scale | FMC CORPORATION (UK) LIMITED (GB) | 1992-04-08 | — | — | EP | claimed |
| US-4973409-A | Treatment of aqueous systems | CIBA-GEIGY CORPORATION (US) | 1990-11-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559704-B2 | Microelectronic device cleaning composition | HCN1, KCNH3, ADH1C | PPARD 4694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.